{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:57:51Z","timestamp":1785592671237,"version":"3.56.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Microbiol Infect Dis"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s10096-026-05521-5","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:45:40Z","timestamp":1777538740000},"page":"2485-2494","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical outcomes and therapeutic approaches in pediatric infections caused by metallo-\u03b2-lactamase\u2013producing organisms: a five-year experience in a tertiary care hospital"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-2334","authenticated-orcid":false,"given":"Costanza","family":"Tripiciano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Bernaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Venere","family":"Cortazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Vrenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenza","family":"Romani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Bottari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Dei Giudici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Fragasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Tortora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Luisa","family":"Ciofi degli Atti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lancella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"5521_CR1","doi-asserted-by":"publisher","unstructured":"European Centre for Disease Prevention and Control. Carbapenem-Resistant Enterobacterales: Third Update. Publications Office (2025) Accessed February 22, 2025. https:\/\/data.europa.eu\/doi\/https:\/\/doi.org\/10.2900\/8752612","DOI":"10.2900\/8752612"},{"key":"5521_CR2","unstructured":"Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. Accessed February 25 (2025) https:\/\/www.who.int\/publications\/i\/item\/WHO-EMP-IAU-2017.12"},{"key":"5521_CR3","doi-asserted-by":"publisher","unstructured":"Centers for Disease Control and Prevention (U.S.) (2019) Antibiotic Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention (U.S.). https:\/\/doi.org\/10.15620\/cdc:82532","DOI":"10.15620\/cdc:82532"},{"key":"5521_CR4","doi-asserted-by":"publisher","unstructured":"Lee YL, Chen HM, Hii IM, Hsueh PR. Carbapenemase-producing Enterobacterales infections: recent advances in diagnosis and treatment. Int J Antimicrob Agents. ;59(2):106528. doi: 10.1016\/j.ijantimicag.2022.106528. Epub 2022 Jan 19. PMID: 35063651. - Macesic N, Uhlemann AC, Peleg AY. Multidrug-resistant Gram-negative bacterial infections. Lancet. 2025;405(10474):257\u2013272. doi: 10.1016\/S0140-6736(24)02081-6. PMID: 39826970. - Simner, Pitout PJ, Dingle JDD (2022) TC. Laboratory detection of carbapenemases among Gram-negative organisms. Clin Microbiol Rev. 2024;37(4):e0005422. https:\/\/doi.org\/10.1128\/cmr.00054-22. Epub 2024 Nov 15. PMID: 39545731; PMCID: PMC11629623.)","DOI":"10.1128\/cmr.00054-22"},{"issue":"9","key":"5521_CR5","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S1473-3099(13)70190-7","volume":"13","author":"LS Munoz-Price","year":"2013","unstructured":"Munoz-Price LS, Poirel L, Bonomo RA et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13(9):785\u2013796. https:\/\/doi.org\/10.1016\/S1473-3099(13)70190-7","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"5521_CR6","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1111\/j.1469-0691.2012.03821.x","volume":"18","author":"R Cant\u00f3n","year":"2012","unstructured":"Cant\u00f3n R, Ak\u00f3va M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen \u00d8, Seifert H, Woodford N, Nordmann P (2012) European Network on Carbapenemases. Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18(5):413\u2013431. https:\/\/doi.org\/10.1111\/j.1469-0691.2012.03821.xPMID: 22507109.)","journal-title":"Clin Microbiol Infect"},{"key":"5521_CR7","volume-title":"CRE: sorveglianza nazionale delle batteriemie da enterobatteri resistenti ai carbapenemi. Dati 2023","author":"S Iacchini","year":"2024","unstructured":"Iacchini S et al (2024) CRE: sorveglianza nazionale delle batteriemie da enterobatteri resistenti ai carbapenemi. Dati 2023. ISS, Roma. https:\/\/www.epicentro.iss.it\/antibiotico-resistenza\/cpe\/RIS-4_2024.pdf"},{"key":"5521_CR8","unstructured":"Antimicrobial resistance in the EU\/EEA (EARS-Net) - Annual epidemiological report for 2023. Published online November 2024. https:\/\/www.ecdc.europa.eu\/en\/publicationsdata\/antimicrobial-resistance-eueea-ears-net-annual-epidemiological-report-2023"},{"issue":"10","key":"5521_CR9","doi-asserted-by":"publisher","first-page":"ofy241","DOI":"10.1093\/ofid\/ofy241","volume":"5","author":"E McCann","year":"2018","unstructured":"McCann E, Srinivasan A, DeRyke CA et al (2018) Carbapenem-Nonsusceptible Gram-Negative Pathogens in ICU and Non-ICU Settings in US Hospitals in 2017: A Multicenter Study. Open Forum Infect Dis 5(10):ofy241. https:\/\/doi.org\/10.1093\/ofid\/ofy241","journal-title":"Open Forum Infect Dis"},{"key":"5521_CR10","doi-asserted-by":"crossref","unstructured":"Pranita D, Tamma EL, Heil JA, Justo AJ, Mathers MJ, Satlin RA, Bonomo (2025) Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections, Clinical Infectious Diseases, 2024;, ciae403. https:\/\/doi.org\/10.1093\/cid\/ciae403. Accessed 25 Feb.\u00a0https:\/\/www.idsociety.org\/practice-guideline\/amr-guidance\/","DOI":"10.1093\/cid\/ciae403"},{"issue":"4","key":"5521_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cmi.2021.11.025","volume":"28","author":"M Paul","year":"2022","unstructured":"Paul M, Carrara E, Retamar P et al (2022) European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine). Clin Microbiol Infect 28(4):521\u2013547. https:\/\/doi.org\/10.1016\/j.cmi.2021.11.025","journal-title":"Clin Microbiol Infect"},{"issue":"7","key":"5521_CR12","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.3390\/microorganisms11071798","volume":"11","author":"F Venuti","year":"2023","unstructured":"Venuti F, Romani L, De Luca M et al (2023) Novel Beta Lactam Antibiotics for the Treatment of Multidrug-Resistant Gram-Negative Infections in Children: A Narrative Review. Microorganisms 11(7):1798. https:\/\/doi.org\/10.3390\/microorganisms11071798","journal-title":"Microorganisms"},{"issue":"2","key":"5521_CR13","doi-asserted-by":"publisher","first-page":"piaf004","DOI":"10.1093\/jpids\/piaf004","volume":"14","author":"CR Lockowitz","year":"2025","unstructured":"Lockowitz CR, Hsu AJ, Chiotos K et al (2025) Suggested Dosing of Select Beta-lactam Agents for the Treatment of Antimicrobial-Resistant Gram-Negative Infections in Children. J Pediatr Infect Dis Soc 14(2):piaf004. https:\/\/doi.org\/10.1093\/jpids\/piaf004","journal-title":"J Pediatr Infect Dis Soc"},{"issue":"1","key":"5521_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3390\/antibiotics13010037","volume":"13","author":"S Mercadante","year":"2023","unstructured":"Mercadante S, Tripiciano C, Romani L et al (2023) The Use of Cefiderocol as Salvage Therapy in an Infant Receiving ECMO and Continuous Renal Replacement Therapy. Antibiot (Basel) 13(1):37. https:\/\/doi.org\/10.3390\/antibiotics13010037","journal-title":"Antibiot (Basel)"},{"issue":"12","key":"5521_CR15","doi-asserted-by":"publisher","first-page":"2216","DOI":"10.1007\/s00134-018-5113-0","volume":"44","author":"D Plachouras","year":"2018","unstructured":"Plachouras D, Lepape A, Suetens C (2018) ECDC definitions and methods for the surveillance of healthcare-associated infections in intensive care units. Intensive Care Med 44(12):2216\u20132218. https:\/\/doi.org\/10.1007\/s00134-018-5113-0","journal-title":"Intensive Care Med"},{"issue":"2","key":"5521_CR16","doi-asserted-by":"publisher","first-page":"298.e1","DOI":"10.1016\/j.cmi.2021.06.031","volume":"28","author":"M Falcone","year":"2022","unstructured":"Falcone M, Tiseo G, Galfo V, Giordano C, Leonildi A, Marciano E, De Simone P, Biancofiore G, Boggi U, Barnini S, Menichetti F, Italian Group of Antimicrobial Stewardship (the GISA study group) (2022) Bloodstream infections in patients with rectal colonization by Klebsiella pneumoniae producing different type of carbapenemases: a prospective, cohort study (CHIMERA study). Clin Microbiol Infect 28(2):298.e1-298.e7. https:\/\/doi.org\/10.1016\/j.cmi.2021.06.031","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"5521_CR17","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1111\/j.1469-0691.2011.03570.x","volume":"18","author":"AP Magiorakos","year":"2012","unstructured":"Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME, Giske CG, Harbarth S, Hindler JF, Kahlmeter G, Olsson-Liljequist B, Paterson DL, Rice LB, Stelling J, Struelens MJ, Vatopoulos A, Weber JT, Monnet DL (2012) Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 18(3):268\u201381. https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03570.x","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"5521_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ (2022) Infectious Diseases Society of America 2022 guidance on the treatment of extended-spectrum \u03b2-lactamase producing Enterobacterales (ESBL-E), carbapenem-resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with difficult-to-treat resistance (DTR-P. aeruginosa). Clin Infect Dis 75(2):187\u2013212. https:\/\/doi.org\/10.1093\/cid\/ciac268","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5521_CR19","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1001\/jama.2024.0179","volume":"331","author":"LJ Schlapbach","year":"2024","unstructured":"Schlapbach LJ, Watson RS, Sorce LR et al (2024) International consensus criteria for pediatric sepsis and septic shock. JAMA 331(8):665\u2013674. https:\/\/doi.org\/10.1001\/jama.2024.0179","journal-title":"JAMA"},{"issue":"2","key":"5521_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.gendis.2019.04.001","volume":"6","author":"P Pachori","year":"2019","unstructured":"Pachori P, Gothalwal R, Gandhi P (2019) Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit; a critical review. Genes Dis 6(2):109\u2013119. https:\/\/doi.org\/10.1016\/j.gendis.2019.04.001","journal-title":"Genes Dis"},{"issue":"6","key":"5521_CR21","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1093\/cid\/cis543","volume":"55","author":"LK Logan","year":"2012","unstructured":"Logan LK (2012) Carbapenem-resistant Enterobacteriaceae: an emerging problem in children. Clin Infect Dis 55(6):852\u20139. https:\/\/doi.org\/10.1093\/cid\/cis543","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5521_CR22","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1097\/INF.0000000000001188","volume":"35","author":"C Montagnani","year":"2016","unstructured":"Montagnani C, Prato M, Scolfaro C, Colombo S, Esposito S, Tagliabue C, Lo Vecchio A, Bruzzese E, Loy A, Cursi L, Vuerich M, de Martino M, Galli L, Italian Society of Pediatric Infectious Diseases (2016) Carbapenem-resistant Enterobacteriaceae infections in children: an Italian retrospective multicenter study. Pediatr Infect Dis J 35(8):862\u20138. https:\/\/doi.org\/10.1097\/INF.0000000000001188","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"5521_CR23","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12050796","volume":"12","author":"C Tripiciano","year":"2023","unstructured":"Tripiciano C, Romani L, Mercadante S, Cursi L, Di Giuseppe M, Calo Carducci FI, Fragasso T, Di Chiara L, Garisto C, Sisto A, Vallesi L, Costabile V, Lancella L, Bernaschi P, De Luca M (2023) The prevalence of Carbapenemase-producing microorganisms and use of novel cephalosporins for the treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria in a pediatric cardiac intensive care unit. Antibiotics 12(5):796. https:\/\/doi.org\/10.3390\/antibiotics12050796","journal-title":"Antibiotics"},{"issue":"1","key":"5521_CR24","doi-asserted-by":"publisher","first-page":"14","DOI":"10.4103\/0974-2727.66701","volume":"2","author":"M Sharma","year":"2010","unstructured":"Sharma M, Yadav S, Chaudhary U (2010) Metallo-beta-lactamase producing Pseudomonas aeruginosa in neonatal septicemia. J Lab Physicians 2(1):14\u20136. https:\/\/doi.org\/10.4103\/0974-2727.66701","journal-title":"J Lab Physicians"},{"issue":"5","key":"5521_CR25","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1093\/cid\/ciad725","volume":"78","author":"M Falcone","year":"2024","unstructured":"Falcone M, Giordano C, Leonildi A, Galfo V, Lepore A, Suardi LR, Riccardi N, Barnini S, Tiseo G (2024) Clinical features and outcomes of infections caused by Metallo-\u03b2-Lactamase-producing Enterobacterales: a 3-year prospective study from an endemic area. Clin Infect Dis 78(5):1111\u20131119. https:\/\/doi.org\/10.1093\/cid\/ciad725","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5521_CR26","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13054-025-05266-1","volume":"29","author":"G De Pascale","year":"2025","unstructured":"De Pascale G, Cortegiani A, Rinaldi M, Antonelli M, Cattaneo S, Cecconi M, Cuffaro R, Dalfino L, Di Biase F, Donati A, Fasano FR, Fasciana T, Foti G, Frattari A, Fumagalli R, Girardis M, Gottin L, Mattei A, Milazzo M, Montrucchio G, Pasero D, Picciafuochi F, Sensi E, Servillo G, Vidal Pereira MA, Spanu T, Viale P, INCREASE-IT Study Group (2025) Incidence of hospital-acquired infections due to carbapenem-resistant Enterobacterales and Pseudomonas aeruginosa in critically ill patients in Italy: a multicentre prospective cohort study. Crit Care 29(1):32. https:\/\/doi.org\/10.1186\/s13054-025-05266-1PMID: 39825453; PMCID: PMC11742785","journal-title":"Crit Care"},{"key":"5521_CR27","doi-asserted-by":"publisher","first-page":"827474","DOI":"10.3389\/fmed.2022.827474","volume":"9","author":"H Yu","year":"2022","unstructured":"Yu H, Ma D, Liu B, Yang S, Lin Q, Yu R, Jia X, Niu S, Zhang Q, Huang S (2022) Differences in the Distribution of Species, Carbapenemases, Sequence Types, Antimicrobial Heteroresistance and Mortality Rates Between Pediatric and Adult Carbapenemase-Producing Enterobacterales in Bloodstream Infections. Front Med (Lausanne) 9:827474. https:\/\/doi.org\/10.3389\/fmed.2022.827474PMID: 35360726; PMCID: PMC8964124","journal-title":"Front Med (Lausanne)"},{"issue":"4","key":"5521_CR28","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/j.jhin.2014.05.007","volume":"87","author":"A Lucena","year":"2014","unstructured":"Lucena A, Dalla Costa LM, Nogueira KS, Matos AP, Gales AC, Paganini MC, Castro ME, Raboni SM (2014) Nosocomial infections with metallo-beta-lactamase-producing Pseudomonas aeruginosa: molecular epidemiology, risk factors, clinical features and outcomes. J Hosp Infect 87(4):234\u2013240 Epub 2014 Jun 20. PMID: 25027563","journal-title":"J Hosp Infect"},{"issue":"3","key":"5521_CR29","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1128\/AAC.01823-12","volume":"57","author":"L Armand-Lef\u00e8vre","year":"2013","unstructured":"Armand-Lef\u00e8vre L, Angebault C, Barbier F, Hamelet E, Defrance G, Rupp\u00e9 E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Pl\u00e9siat P, Andremont A (2013) Emergence of imipenem-resistant gram-negative bacilli in intestinal flora of intensive care patients. Antimicrob Agents Chemother 57(3):1488\u20131495. https:\/\/doi.org\/10.1128\/AAC.01823-12Epub 2013 Jan 14. PMID: 23318796; PMCID: PMC3591916","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"5521_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-020-02051-8","volume":"20","author":"F Mahmoodi","year":"2020","unstructured":"Mahmoodi F, Rezatofighi SE, Akhoond MR (2020) Antimicrobial resistance and metallo-beta-lactamase producing among commensal Escherichia coli isolates from healthy children of Khuzestan and Fars provinces; Iran. BMC Microbiol 20(1):366. https:\/\/doi.org\/10.1186\/s12866-020-02051-8","journal-title":"BMC Microbiol"},{"key":"5521_CR31","unstructured":"Centers for Disease Control and Prevention, MDRO Prevention and Control, 12 April 2024. https:\/\/www.cdc.gov\/infection-control\/hcp\/mdro-management\/prevention-control.html"},{"key":"5521_CR32","doi-asserted-by":"crossref","unstructured":"Russo C, Mesini A, Mariani M, Tavella E, Sette C, Ugolotti E, Bartalucci C, Palmero C, Bandettini R, Castagnola E. Reduce susceptibility to cefiderocol in gram negative bacteria in children: Is hope already lost before it's even arrived? (2024) J Infect Public Health. 17(4):624-631. 10.1016\/j.jiph.2024.02.006. Epub 2024 Feb 12. PMID: 38422857.","DOI":"10.1016\/j.jiph.2024.02.006"},{"key":"5521_CR33","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.cmi.2023.08.029","volume":"30","author":"S Karakonstantis","year":"2024","unstructured":"Karakonstantis S, Rousaki M, Vassilopoulou L, Kritsotakis EI (2024) Global prevalence of cefiderocol non-susceptibility in Enterobacterales, Pseudomonas aeruginosa, Acinetobacter baumannii and Stenotrophomonas maltophilia: a systematic review and meta-analysis. Clin Microbiol Infect 30:178\u2013188","journal-title":"Clin Microbiol Infect"},{"key":"5521_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s40273-025-01528-6","author":"M Falcone","year":"2025","unstructured":"Falcone M, Bao X, Woodcock F, Di Virgilio R, Vidal Pereira MA, Kantecki M, Gheorghe M (2025) Cost-effectiveness analysis of Aztreonam-Avibactam (ATM-AVI) versus Colistin\u2009+\u2009Meropenem (COL\u2009+\u2009MER) for the treatment of infections caused by Metallo-\u03b2-lactamase (MBL)-producing Enterobacterales in Italy. Pharmacoeconomics. https:\/\/doi.org\/10.1007\/s40273-025-01528-6","journal-title":"Pharmacoeconomics"},{"issue":"3","key":"5521_CR35","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/j.1540-8191.2008.00791.x","volume":"24","author":"Y Kato","year":"2009","unstructured":"Kato Y, Ohashi H, Tsutsumi Y, Murakami T, Takahashi Y (2009) Prosthetic valve endocarditis caused by metallo-beta-lactamase-producing Pseudomonas aeruginosa. J Card Surg 24(3):347\u20139. https:\/\/doi.org\/10.1111\/j.1540-8191.2008.00791.x","journal-title":"J Card Surg"},{"issue":"12","key":"5521_CR36","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/cid\/ciad100","volume":"76","author":"M Falcone","year":"2023","unstructured":"Falcone M et al (2023) Mortality attributable to bloodstream infections caused by different Carbapenem-resistant Gram-negative bacilli: Results from a nationwide study in Italy (ALARICO Network). Clin Infect Dis 76(12):2059\u20132069. https:\/\/doi.org\/10.1093\/cid\/ciad100","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5521_CR37","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13054-020-2742-9","volume":"24","author":"M Falcone","year":"2020","unstructured":"Falcone M, Bassetti M, Tiseo G, Giordano C, Nencini E, Russo A, Graziano E, Tagliaferri E, Leonildi A, Barnini S, Farcomeni A, Menichetti F (2020) Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae. Crit Care 24(1):29. https:\/\/doi.org\/10.1186\/s13054-020-2742-9PMID: 32000834; PMCID: PMC6993311","journal-title":"Crit Care"},{"key":"5521_CR38","doi-asserted-by":"publisher","first-page":"649","DOI":"10.2217\/fmb-2019-0333","volume":"15","author":"MJC Campos","year":"2020","unstructured":"Campos MJC, Antunes LC, Ferreira RB (2020) Global priority pathogens: virulence, antimicrobial resistance and prospective treatment options. Future Microbiol 15:649\u2013677. https:\/\/doi.org\/10.2217\/fmb-2019-0333","journal-title":"Future Microbiol"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10096-026-05521-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10096-026-05521-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T13:11:55Z","timestamp":1785589915000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10096-026-05521-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":38,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5521"],"URL":"https:\/\/doi.org\/10.1007\/s10096-026-05521-5","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"14 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was reviewed and approved by the institutional ethics committee in accordance with applicable regulations and ethical standards [protocol number n\u00b0 3223\/2023, date of approval 04th October 2023]. Written informed consent was obtained from the parents.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}